Abstract
Promyelocytic Leukemia (PML) is a nuclear protein that forms sub-nuclear structures termed nuclear bodies associated with transcriptionally active genomic regions. PML is a tumour suppressor and regulator of cell differentiation. We demonstrate that PML promotes TNFα-induced transcriptional responses by promoting NF-κ B activity. TNFα-treated PML -/- cells show normal IκBα degradation and NF-κ B nuclear translocation but significantly reduced NF-κ B DNA binding and phosphorylation of NF-κ B p65. We also demonstrate that the PML retinoic acid receptor-α (PML-RARα) oncofusion protein, which causes acute promyelocytic leukemia, inhibits TNFα induced gene expression and phosphorylation of NF-κ B. This study establishes PML as an important regulator of NF-κ B and demonstrates that PML-RARα dysregulates NF-κ B.
| Original language | English |
|---|---|
| Article number | 44539 |
| Journal | Scientific Reports |
| Volume | 7 |
| DOIs | |
| Publication status | Published - 20 Mar 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Regulation of NF-κ B by PML and PML-RARα'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver